Kilitch Drugs Delivers 212 Per Cent PAT Growth in Q4FY25 on Robust Global Demand
Kilitch Drugs continues to scale its operations in both domestic and international markets, offering a wide range of pharmaceutical products.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed